These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36986637)

  • 1. [
    Nock BA; Kanellopoulos P; Moon ES; Rouchota M; Loudos G; Ballal S; Yadav MP; Bal C; Mishra P; Sheokand P; Roesch F; Maina T
    Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Kanellopoulos P; Nock BA; Greifenstein L; Baum RP; Roesch F; Maina T
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAZTA
    Sinnes JP; Nagel J; Rösch F
    EJNMMI Radiopharm Chem; 2019 Aug; 4(1):18. PubMed ID: 31659525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of a novel, versatile bifunctional chelator on theranostic properties of a minigastrin analogue.
    Pfister J; Summer D; Rangger C; Petrik M; von Guggenberg E; Minazzi P; Giovenzana GB; Aloj L; Decristoforo C
    EJNMMI Res; 2015 Dec; 5(1):74. PubMed ID: 26669693
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Sinnes JP; Bauder-Wüst U; Schäfer M; Moon ES; Kopka K; Rösch F
    EJNMMI Radiopharm Chem; 2020 Nov; 5(1):28. PubMed ID: 33242189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head-to-Head Comparison of SSTR Antagonist [
    Viswanathan R; Ballal S; Yadav MP; Roesch F; Sheokand P; Satapathy S; Tripathi M; Agarwal S; Moon ES; Bal C
    Pharmaceuticals (Basel); 2024 Feb; 17(3):. PubMed ID: 38543061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAZTA
    Klasen B; Moon ES; Rösch F
    Nucl Med Biol; 2021; 96-97():80-93. PubMed ID: 33839678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution, Pharmacokinetics, and Dosimetry of
    Nicolas GP; Mansi R; McDougall L; Kaufmann J; Bouterfa H; Wild D; Fani M
    J Nucl Med; 2017 Sep; 58(9):1435-1441. PubMed ID: 28450554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the versatile bifunctional chelator AAZTA
    Hofstetter M; Moon ES; D'Angelo F; Geissbühler L; Alberts I; Afshar-Oromieh A; Rösch F; Rominger A; Gourni E
    EJNMMI Radiopharm Chem; 2020 Nov; 5(1):29. PubMed ID: 33258012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA
    Moon ES; Van Rymenant Y; Battan S; De Loose J; Bracke A; Van der Veken P; De Meester I; Rösch F
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34201111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin Receptor Antagonists for Imaging and Therapy.
    Fani M; Nicolas GP; Wild D
    J Nucl Med; 2017 Sep; 58(Suppl 2):61S-66S. PubMed ID: 28864614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.
    Nock BA; Kaloudi A; Lymperis E; Giarika A; Kulkarni HR; Klette I; Singh A; Krenning EP; de Jong M; Maina T; Baum RP
    J Nucl Med; 2017 Jan; 58(1):75-80. PubMed ID: 27493272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of
    Krebs S; O'Donoghue JA; Biegel E; Beattie BJ; Reidy D; Lyashchenko SK; Lewis JS; Bodei L; Weber WA; Pandit-Taskar N
    Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3047-3057. PubMed ID: 32378020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [
    Tatsi A; Maina T; Waser B; Krenning EP; de Jong M; Reubi JC; Cordopatis P; Nock BA
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid Chelator-Based PSMA Radiopharmaceuticals: Translational Approach.
    Lahnif H; Grus T; Pektor S; Greifenstein L; Schreckenberger M; Rösch F
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and preclinical evaluation of a novel bifunctional macrocyclic chelator for theranostics of cancers.
    Xu J; Cai F; Luo Z; Fan W; Dai J; Cui J; Li S; Geng C; Zheng Q; Wang Z; Tang X
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2618-2633. PubMed ID: 35347438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference.
    Fani M; Del Pozzo L; Abiraj K; Mansi R; Tamma ML; Cescato R; Waser B; Weber WA; Reubi JC; Maecke HR
    J Nucl Med; 2011 Jul; 52(7):1110-8. PubMed ID: 21680701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonpeptidic Z360-Analogs Tagged with Trivalent Radiometals as Anti-CCK
    Nock BA; Kanellopoulos P; Chepurny OG; Rouchota M; Loudos G; Holz GG; Krenning EP; Maina T
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of novel macrocyclic chelates on the targeting properties of the
    Wang Y; Yuan H; Tang S; Liu Y; Cai P; Liu N; Chen Y; Zhou Z
    EJNMMI Res; 2023 Jun; 13(1):56. PubMed ID: 37285007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, preparation and biological evaluation of a
    Behnammanesh H; Jokar S; Erfani M; Geramifar P; Sabzevari O; Amini M; Mazidi SM; Hajiramezanali M; Beiki D
    Bioorg Chem; 2020 Jan; 94():103381. PubMed ID: 31662215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.